Elsevier

Epilepsy Research

Volume 15, Issue 3, July 1993, Pages 207-219
Epilepsy Research

Research report
Pharmacological characterization of phenytoin-resistant amygdala-kindled rats, a new model of drug-resistant partial epilepsy

https://doi.org/10.1016/0920-1211(93)90058-FGet rights and content

Abstract

By repeated treatment with phenytoin, subgroups of animals with different response to phenytoin were selected from a large group of amygdala-kindled rats. In one subgroup (‘phenytoin responders’) phenytoin induced reproducible increases in focal seizure threshold, while in another subgroup (‘phenytoin nonresponders’) animals were resistant to phenytoin. These phenytoin nonresponders, which comprised about 12% of the kindled animals tested, did not differ from phenytoin responders in drug levels, drug adverse effects or location of the stimulation electrode in the amygdala. Treatment of phenytoin responders and nonresponders with other primary antiepileptic drugs showed that valproate and phenobarbital induced much smaller increases in focal seizure threshold in phenytoin nonresponders than in responders, whereas carbamazepine induced about the same threshold increase in both groups. The novel antiepileptic drug vigabatrin, which acts by increasing GABA levels, exerted anticonvulsant effects in phenytoin responders but was inactive in nonresponders. Determination of plasma amino acids before and after vigabatrin treatment demonstrated marked differences in biochemical responses to vigabatrin although drug levels were about the same in both groups. The data demonstrate that amygdalakindled rats with phenytoin resistance offer a basic approach to the investigation of mechanisms of drug resistance in epilepsy. Furthermore, these animals may be used in the evaluation of new anticonvulsant drugs for treatment of partial seizures which do not respond to the currently available therapies.

References (38)

  • C. Rundfeldt et al.

    Phenytoin potently increases the threshold for focal seizures in amygdalakindled rats

    Neuropharmacology

    (1990)
  • C. Rundfeldt et al.

    Development of tolerance to the anticonvulsant effect of vigabatrin in amygdala-kindled rats

    Eur. J. Pharmacol.

    (1992)
  • M. Sato et al.

    Kindling: basic mechanisms and clinical validity

    Electroenceph. Clin. Neurophysiol.

    (1990)
  • P.S. Albright et al.

    Development of a new pharmacological seizure model: effects of anticonvulsants on cortical- and amygdala-kindled seizures in the rat

    Epilepsia

    (1980)
  • M.C. Anderson et al.

    Pentylenetetrazole (PTZ) kindling in diazepam-sensitive and -resistant mice

    Soc. Neurosci. Abstr.

    (1991)
  • E. Ben-Menachem

    Pharmacokinetic effects of vigabatrin on cerebrospinal fluid amino acids in humans

    Epilepsia

    (1989)
  • M. Dam

    Intractable epilepsy: Introduction

  • H.-H. Frey et al.

    Anti-convulsant effect of primidone in the gerbil. Time course and significance of the active metabolites

    Pharmacology

    (1984)
  • E.J. Gallaher et al.

    Mouse lines selected for genetic differences in diazepam sensitivity

    Psychopharmacology

    (1987)
  • Cited by (0)

    View full text